Colin Halford

Title: Colin Halford: Innovator in Antibiotic Susceptibility Testing

Introduction

Colin Halford is a notable inventor based in Los Angeles, CA, who has made significant contributions to the field of antibiotic susceptibility testing. His innovative approach utilizes probes for preribosomal RNA to detect antibiotic resistance, which is crucial for effective treatment strategies.

Latest Patents

Colin Halford holds a patent for "Antibiotic susceptibility testing using probes for preribosomal RNA." This patent describes probes and methods for detecting antibiotic susceptibility of a specimen. The method involves contacting the specimen with an oligonucleotide probe that specifically hybridizes with a target nucleic acid sequence region of ribosomal RNA. The target sequence is located at the junction between a pre-ribosomal RNA tail and mature ribosomal RNA of 23S or 16S rRNA. By performing the method in the presence and absence of an antibiotic, it allows for the detection of antibiotic susceptibility.

Career Highlights

Throughout his career, Colin Halford has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work has had a significant impact on the field of microbiology and antibiotic resistance.

Collaborations

Colin has collaborated with notable individuals such as David A. Haake and Jane T. Babbitt, contributing to advancements in his area of expertise.

Conclusion

Colin Halford's innovative work in antibiotic susceptibility testing highlights the importance of research in combating antibiotic resistance. His contributions continue to influence the medical field and improve patient outcomes.